Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-13

Clinical Trial Update: ED50 of Intratecal Prilocaine in Ultrasound Fusion Prostate Biopsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the ED50 of intrathecal prilocaine used during ultrasound fusion prostate biopsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prilocaine (prilocaine)

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Evaluate Requirements of 2% Prilocaine in MR-UF Prostate Biopsy | Phase 4 | Status: UNKNOWN